Cargando…
A summary of the Japan septic disseminated intravascular coagulation study
Over the past few decades, the large, international, randomized controlled trials of anticoagulant therapies for patients with sepsis have not yielded any improvement in mortality rates. However, in Japan, anticoagulant therapies are administered for sepsis patients with disseminated intravascular c...
Autores principales: | Hayakawa, Mineji, Ono, Kota |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5891114/ https://www.ncbi.nlm.nih.gov/pubmed/29657722 http://dx.doi.org/10.1002/ams2.326 |
Ejemplares similares
-
Pathophysiology of trauma-induced coagulopathy: disseminated intravascular coagulation with the fibrinolytic phenotype
por: Hayakawa, Mineji
Publicado: (2017) -
Management of disseminated intravascular coagulation: current insights on antithrombin and thrombomodulin treatments
por: Hayakawa, Mineji
Publicado: (2017) -
Real‐world evidence on disseminated intravascular coagulation from Japan
por: Hisamune, Ryo, et al.
Publicado: (2023) -
Sepsis‐induced disseminated intravascular coagulation: an international estrangement of disease concept
por: Ushio, Noritaka, et al.
Publicado: (2023) -
Optimal Antithrombin Activity Threshold for Initiating Antithrombin Supplementation in Patients With Sepsis-Induced Disseminated Intravascular Coagulation: A Multicenter Retrospective Observational Study
por: Hayakawa, Mineji, et al.
Publicado: (2018)